1d
Zacks Investment Research on MSNIs it the Right Time to Hold Alcon Stock in Your Portfolio Now?Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...
Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, is most implanted IOL in the world. It was the first IOL to be ...
Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, has been implanted in more than 135 million eyes, making it ...
Hosted on MSN2mon
Alcon Top Pick for 2025 at Needham, added to Conviction ListThe firm’s analysis indicates that Alcon's end markets, particularly in cataracts and contact lenses, should perform robustly in 2025. The survey of US doctors suggests strong intraocular lens ...
CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching ... UNITY VCS surgical platform, PanOptix Pro intraocular lens, and the Voyager laser trabeculoplasty ...
EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...
The department of Ophthalmology at Father Muller Medical College (FMMC), under the aegis of SKOS and ALCON, successfully ...
In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the meeting.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results